Therasense

Inequitable Conduct After Therasense: Definitely Harder to Prove

Specific intent to deceive the USPTO did not exist where an inventor removed mention of a reference from his patent application, and then testified that the “reference was cumulative or merely provided background information… Read More

Upcoming Webinar

Tom Bejin will provide a primer on patent damages.  Patent Damages is a complex issue involving much more than just lost profits and reasonable royalties.  The webinar will review basic principles and highlight latest trends.     Register

Subscribe